Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana

November 21, 2019 updated by: National Institute on Drug Abuse (NIDA)

Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana

The objective of this study is to assess the effects of oral cannabidiol (CBD; 0, 200, 400, 800 mg) on smoked marijuana's (0, 5.6% THC) subjective, reinforcing, cognitive, and cardiovascular effects. This experiment is expected to reveal CBD's intrinsic effects when combined with placebo marijuana, as well as its ability to modulate the behavioral effects of active marijuana.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Marijuana contains many chemicals called cannabinoids. The ingredient mainly responsible for marijuana's psychoactive effects is called THC (delta-9-tetrahydrocannabinol. Another cannabinoid in marijuana is cannabidiol. It is found in smaller quantities than THC. Cannabidiol is thought to interfere with the effects of THC. Therefore, synthetically produced cannabidiol is given to healthy marijuana users in this study to test its capability to reduce the high of THC and, thereby, help to relieve addiction to marijuana.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40513
        • University of Kentucky, Straus Behavioral Research Bldg., 515 Oldham Ct.
    • New York
      • New York, New York, United States, 10032
        • Marijuana Outpatient Lab 1051 Riverside Dr. Unit #120
    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Center for Drug and Alcohol Programs, Room 459 North, 67 President St.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 48 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults between the ages of 18 and 50.
  • Current marijuana use: Minimum of four times per week, 0.5 joints per occasion during the preceding 4 weeks.
  • Able to perform study procedures
  • Women practicing an effective form of birth control

Exclusion Criteria:

  • Female subjects who are currently pregnant or breastfeeding.
  • Current, repeated illicit drug use other than marijuana
  • Presence of significant medical illness
  • History of heart disease
  • Request for drug treatment
  • Current parole or probation
  • Recent history of significant violent behavior
  • Major psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Active marijuana (MJ) with 0 mg CBD
Active MJ cigarettes contain 5.30% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Active MJ with 200 mg CBD
Active MJ cigarettes contain 5.30% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Active MJ with 400 mg CBD
Active MJ cigarettes contain 5.30% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Active MJ with 800 mg CBD
Active MJ cigarettes contain 5.30% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Inactive MJ with 0 mg CBD
Inactive MJ cigarettes contain 0.01% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Inactive MJ with 200 mg CBD
Inactive MJ cigarettes contain 0.01% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Inactive MJ with 400 mg CBD
Inactive MJ cigarettes contain 0.01% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD
Other: Inactive MJ with 800 mg CBD
Inactive MJ cigarettes contain 0.01% THC
Each subject in the study was tested on eight days, each day receiving a different combination of active/inactive cannabis cigarettes plus 0, 200, 400 or 800 mg of CBD in random order. Cigarettes contained either 0.01 or 5.30% THC. At each visit, participants were given four gelatin capsules containing lactose and 0 or 200 mg of CBD in combinations to achieve scheduled dose level.
Other Names:
  • cannabidiol is abbreviated CBD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood Scale - Subscale 'Feeling High'
Time Frame: two hours before and after marijuana cigarette smoking
Participants rated how much they felt having a "high" feeling from smoked marijuana using a visual analog scale 1-100 mm, 1 (Not at all) - 100 (extremely).
two hours before and after marijuana cigarette smoking

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marijuana Rating Form - Like
Time Frame: 15 - 120 minutes after marijuana cigarette smoking
Participants rated how much they liked the effects of smoked marijuana using a visual analog scale 1-100 mm, 1=least, 100= most
15 - 120 minutes after marijuana cigarette smoking
Marijuana Rating Form - Strength
Time Frame: 15 - 120 minutes after marijuana cigarette smoking
Participants rated the strength effects of smoked marijuana using a visual analog scale 1-100 mm, 1=least, 100= most
15 - 120 minutes after marijuana cigarette smoking
Optional Additional Puffs of MJ Cigarette
Time Frame: 150 to 250 minutes after first marijuana cigarette was smoked earlier in the day
Participants were allowed to choose to take or reject additional puffs of the same type of MJ cigarette they smoked earlier in the day. Counts of participants choosing to take additional puffs are reported.
150 to 250 minutes after first marijuana cigarette was smoked earlier in the day
Number of Optional Puffs of MJ Cigarette Taken
Time Frame: 150 to 160 minutes after first marijuana cigarette was smoked earlier in the day
Mean number of puffs taken by those participants who chose to take additional puffs.
150 to 160 minutes after first marijuana cigarette was smoked earlier in the day
Heart Rate
Time Frame: 120 minutes before and 150 minutes after marijuana cigarette smoking
Heart rate measured at 10 time points, 4 before and 6 after smoking cannabis.
120 minutes before and 150 minutes after marijuana cigarette smoking
Plasma Concentration of CBD
Time Frame: 6 hours
Plasma concentrations of cannabidiol were measured at six time points after oral administration of four 200 mg capsules of CBD.
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margaret Haney, M.D., New York State Psychiatric Institute
  • Study Director: Robert J Malcolm, M.D., Medical University of South Carolina
  • Study Director: Sharon Walsh, Ph.D., University of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

April 29, 2013

First Submitted That Met QC Criteria

April 29, 2013

First Posted (Estimate)

May 1, 2013

Study Record Updates

Last Update Posted (Actual)

December 9, 2019

Last Update Submitted That Met QC Criteria

November 21, 2019

Last Verified

April 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking, Marijuana

Clinical Trials on CBD

3
Subscribe